FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304136249> ?p ?o ?g. }

• W4304136249 endingPage "100459" @default.
• W4304136249 startingPage "100459" @default.
• W4304136249 abstract "With the aging of the population in worldwide, valvular heart disease has become one of the most prominent life-threatening diseases in human health, and heart valve replacement surgery is one of the therapeutic methods for valvular heart disease. Currently, commercial bioprosthetic heart valves (BHVs) for clinical application are prepared with xenograft heart valves or pericardium crosslinked by glutaraldehyde. Due to the residual cell toxicity from glutaraldehyde, heterologous antigens, and immune response, there are still some drawbacks related to the limited lifespan of bioprosthetic heart valves, such as thrombosis, calcification, degeneration, and defectiveness of re-endothelialization. Therefore, the problems of calcification, defectiveness of re-endothelialization, and poor biocompatibility from the use of bioprosthetic heart valve need to be solved. In this study, hydrogel hybrid heart valves with improved anti-calcification and re-endothelialization were prepared by taking decellularized porcine heart valves as scaffolds following grafting with double bonds. Then, the anti-biofouling zwitterionic monomers 2-methacryloyloxyethyl phosphorylcholine (MPC) and vascular endothelial growth factor (VEGF) were utilized to obtain a hydrogel-coated hybrid heart valve (PEGDA-MPC-DHVs@VEGF). The results showed that fewer platelets and thrombi were observed on the surface of the PEGDA-MPC-DHVs@VEGF. Additionally, the PEGDA-MPC-DHVs@VEGF exhibited excellent collagen stability, biocompatibility and re-endothelialization potential. Moreover, less calcification deposition and a lower immune response were observed in the PEGDA-MPC-DHVs@VEGF compared to the glutaraldehyde-crosslinked DHVs (Glu-DHVs) after subcutaneous implantation in rats for 30 days. These studies demonstrated that the strategy of zwitterionic hydrogels loaded with VEGF may be an effective approach to improving the biocompatibility, anti-calcification and re-endothelialization of bioprosthetic heart valves." @default.
• W4304136249 created "2022-10-11" @default.
• W4304136249 creator A5017920125 @default.
• W4304136249 creator A5018523807 @default.
• W4304136249 creator A5058550256 @default.
• W4304136249 creator A5063194156 @default.
• W4304136249 creator A5083055137 @default.
• W4304136249 creator A5085690411 @default.
• W4304136249 creator A5086326013 @default.
• W4304136249 date "2022-12-01" @default.
• W4304136249 modified "2023-10-11" @default.
• W4304136249 title "Hybrid heart valves with VEGF-loaded zwitterionic hydrogel coating for improved anti-calcification and re-endothelialization" @default.
• W4304136249 cites W1521887445 @default.
• W4304136249 cites W1537794909 @default.
• W4304136249 cites W2027065592 @default.
• W4304136249 cites W2054721583 @default.
• W4304136249 cites W2112352595 @default.
• W4304136249 cites W2134926355 @default.
• W4304136249 cites W2196286023 @default.
• W4304136249 cites W2324952485 @default.
• W4304136249 cites W2528826829 @default.
• W4304136249 cites W2565451362 @default.
• W4304136249 cites W2606939758 @default.
• W4304136249 cites W2609543379 @default.
• W4304136249 cites W2612498605 @default.
• W4304136249 cites W2742497095 @default.
• W4304136249 cites W2754238677 @default.
• W4304136249 cites W2756797184 @default.
• W4304136249 cites W2770784319 @default.
• W4304136249 cites W2789577941 @default.
• W4304136249 cites W2790010649 @default.
• W4304136249 cites W2794244135 @default.
• W4304136249 cites W2804728547 @default.
• W4304136249 cites W2809390957 @default.
• W4304136249 cites W2885298423 @default.
• W4304136249 cites W2888455562 @default.
• W4304136249 cites W2896505558 @default.
• W4304136249 cites W2911957631 @default.
• W4304136249 cites W2913257775 @default.
• W4304136249 cites W2928414693 @default.
• W4304136249 cites W2949765238 @default.
• W4304136249 cites W2969225669 @default.
• W4304136249 cites W2972105099 @default.
• W4304136249 cites W2991541159 @default.
• W4304136249 cites W3009559036 @default.
• W4304136249 cites W3010602414 @default.
• W4304136249 cites W3012532511 @default.
• W4304136249 cites W3033316221 @default.
• W4304136249 cites W3043645363 @default.
• W4304136249 cites W3080783095 @default.
• W4304136249 cites W3081338055 @default.
• W4304136249 cites W3084048358 @default.
• W4304136249 cites W3084196559 @default.
• W4304136249 cites W3084292985 @default.
• W4304136249 cites W3094421007 @default.
• W4304136249 cites W3097511639 @default.
• W4304136249 cites W3107431175 @default.
• W4304136249 cites W3113653293 @default.
• W4304136249 cites W3113922726 @default.
• W4304136249 cites W3114906134 @default.
• W4304136249 cites W3118556278 @default.
• W4304136249 cites W3125157200 @default.
• W4304136249 cites W3128511783 @default.
• W4304136249 cites W3153366187 @default.
• W4304136249 cites W3154605818 @default.
• W4304136249 cites W3185541137 @default.
• W4304136249 cites W3197950707 @default.
• W4304136249 cites W3199563602 @default.
• W4304136249 cites W4200210791 @default.
• W4304136249 cites W4220970561 @default.
• W4304136249 cites W4281771574 @default.
• W4304136249 cites W4282558205 @default.
• W4304136249 cites W4285735554 @default.
• W4304136249 cites W3162145040 @default.
• W4304136249 doi "https://doi.org/10.1016/j.mtbio.2022.100459" @default.
• W4304136249 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36278142" @default.
• W4304136249 hasPublicationYear "2022" @default.
• W4304136249 type Work @default.
• W4304136249 citedByCount "1" @default.
• W4304136249 countsByYear W43041362492023 @default.
• W4304136249 crossrefType "journal-article" @default.
• W4304136249 hasAuthorship W4304136249A5017920125 @default.
• W4304136249 hasAuthorship W4304136249A5018523807 @default.
• W4304136249 hasAuthorship W4304136249A5058550256 @default.
• W4304136249 hasAuthorship W4304136249A5063194156 @default.
• W4304136249 hasAuthorship W4304136249A5083055137 @default.
• W4304136249 hasAuthorship W4304136249A5085690411 @default.
• W4304136249 hasAuthorship W4304136249A5086326013 @default.
• W4304136249 hasBestOaLocation W43041362493 @default.
• W4304136249 hasConcept C126322002 @default.
• W4304136249 hasConcept C136229726 @default.
• W4304136249 hasConcept C142724271 @default.
• W4304136249 hasConcept C185592680 @default.
• W4304136249 hasConcept C190672674 @default.
• W4304136249 hasConcept C191897082 @default.
• W4304136249 hasConcept C192562407 @default.
• W4304136249 hasConcept C2776229121 @default.
• W4304136249 hasConcept C2777230088 @default.

• next